Bioavailability of angiotensin I converting enzyme inhibitory peptides.
about
Bioactive peptides from muscle sources: meat and fishEffect of peptides derived from food proteins on blood pressure: a meta-analysis of randomized controlled trialsMilk derived bioactive peptides and their impact on human health - A reviewInhibition mechanism and model of an angiotensin I-converting enzyme (ACE)-inhibitory hexapeptide from yeast (Saccharomyces cerevisiae)Algal Proteins: Extraction, Application, and Challenges Concerning Production.Peptides reproducibly released by in vivo digestion of beef meat and trout flesh in pigs.STRUCTURAL CHARACTERISTICS AND ANTIHYPERTENSIVE EFFECTS OF ANGIOTENSIN-I-CONVERTING ENZYME INHIBITORY PEPTIDES IN THE RENIN-ANGIOTENSIN AND KALLIKREIN KININ SYSTEMS.Lactotripeptides and antihypertensive effects: a critical review.Blood pressure-lowering peptides from neo-fermented buckwheat sprouts: a new approach to estimating ACE-inhibitory activityBioactive properties and clinical safety of a novel milk protein peptide.Enhanced Lacto-Tri-Peptide Bio-Availability by Co-Ingestion of Macronutrients.Marine Peptides: Bioactivities and ApplicationsPeptides-Derived from Thai Rice Bran Improves Endothelial Function in 2K-1C Renovascular Hypertensive RatsCasein fermentate of Lactobacillus animalis DPC6134 contains a range of novel propeptide angiotensin-converting enzyme inhibitors.Bioactive peptides and depsipeptides with anticancer potential: sources from marine animalsHealth-Promoting Properties of Lactobacillus helveticus.Acute ingestion of a novel whey-derived peptide improves vascular endothelial responses in healthy individuals: a randomized, placebo controlled trialSuppression of tumour growth by orally administered osteopontin is accompanied by alterations in tumour blood vessels.Separation and Characterization of Angiotensin I Converting Enzyme (ACE) Inhibitory Peptides from Saurida elongata Proteins Hydrolysate by IMAC-Ni2.Enzyme-Assisted Discovery of Antioxidant Peptides from Edible Marine Invertebrates: A Review.Milk protein peptides with angiotensin I-converting enzyme inhibitory (ACEI) activity.The potential role of milk-derived peptides in cardiovascular disease.Review: Production and functionality of active peptides from milk.Nanocarrier possibilities for functional targeting of bioactive peptides and proteins: state-of-the-art.Mechanisms and prospects of food protein hydrolysates and peptide-induced hypolipidaemia.Physiological properties of milk ingredients released by fermentation.Bioactive natural constituents from food sources-potential use in hypertension prevention and treatment.The impact of milk proteins and peptides on blood pressure and vascular function: a review of evidence from human intervention studies.Isolation and characterization of peptides with antihypertensive activity in foodstuffs.Inhibition of Angiotensin Converting Enzyme, Angiotensin II Receptor Blocking, and Blood Pressure Lowering Bioactivity across Plant Families.A Review of Potential Marine-derived Hypotensive and Anti-obesity Peptides.Bioactive peptides of animal origin: a review.Nutraceuticals for blood pressure control.Therapeutic potential of dairy bioactive peptides: A contemporary perspective.Food-derived immunomodulatory peptides.Potential antimicrobial and antiproliferative activities of autochthonous starter cultures and protease EPg222 in dry-fermented sausages.Intestinal barrier dysfunction: implications for chronic inflammatory conditions of the bowel.Bioavailability of milk protein-derived bioactive peptides: a glycaemic management perspective.Angiotensin-I-Converting Enzyme (ACE)-Inhibitory Peptides from Plants.Bioactive Peptides in Animal Food Products.
P2860
Q24610066-0FF15856-127F-46D1-A276-57655871E6BBQ24649580-CB405E82-D69B-45B3-90A2-07F7507169C4Q28067784-34B9D0E7-A038-41FA-A831-4940D9910C0CQ28483656-481CAF2C-DA7B-4B07-8681-57D5D03C6F0DQ30355585-B80F7C46-42F5-4FF8-84F4-015CA8D3FDFBQ33296349-BADDFC0C-5E72-4E79-802F-42C19EC4C481Q33732962-0562C77C-AA5E-434F-A725-5A9755FD84DBQ34015048-1FC9C473-33FE-47BE-B483-BC161BE815F6Q35253120-F142A647-246E-4DD9-AE4D-EFBECC1E1CD7Q35386537-9DCB368B-214C-4F0D-8F3D-A43A0F234FD9Q35670341-66072592-A104-4452-9041-AD5D25444EE8Q35890691-D2088F75-3DBD-4B54-8949-2C70D09728ACQ35895079-AF11D7D8-2AB2-412D-A7CC-BC42B65191BCQ35913360-E437BA60-87E6-4906-9F83-B04445AE36F9Q36096750-F25441B9-68D9-4632-8861-B20858014AACQ36407339-16E0C20A-22CB-4300-80E8-364E9CE86A26Q37295459-0019019A-77C8-4304-BBE1-66BB34DD3DA9Q37632122-CDDF2BD9-8844-43EA-AC4D-EB058B604FADQ37678284-28B789BB-E536-45CC-ABCD-E6A6E3948A5DQ37678309-F0928E8B-B979-43AA-A767-E20340F6043FQ37725759-52400B55-2A8B-4EBB-BA4C-22F9421A304DQ37903711-E88AF7EB-9983-44F1-977B-40C168B76F4BQ37932194-CA29AABB-13BB-484C-8A41-C7DCB0AF7181Q37948968-C96B3594-3EBB-4C3A-869E-82D60BEABE4AQ38056363-8EFED714-B8CD-4D50-BCB7-FC3186BDDBCFQ38056616-37ED1C71-666F-42DF-9390-9CFF1CBF333AQ38102733-7E7A889E-5DB9-4588-A83E-AAD662FD0D3BQ38153545-5851D162-7E42-4E03-ACC2-CAB9094A00F9Q38219153-9AE56985-1898-4C5E-99BA-D407D5BDE144Q38219179-FDC1999D-9690-42F3-A96B-84E93C252530Q38311340-FDBB496E-2E18-4B1C-AE4F-AC607CA29CEAQ38582170-85549AEA-1B09-46EC-AA9C-9E36FE6D2385Q38585203-F438F980-B183-4F05-9351-0D9914AC7615Q38725364-CE1798FB-5C6F-4C90-B47E-C0167B9FFDD4Q38759467-842715A3-D989-497E-91C1-112833DB5E47Q38775576-EAE39211-BDC7-4CB2-8B8E-2E823406B734Q38810502-CFCDC5D9-4E19-44A7-9952-C5AC1D9CA5F3Q38876788-0EB26B1D-D9B9-4860-8D2A-3D094AD2F64FQ39195492-01E9768B-1A33-4C9E-A4EE-667287465825Q39293788-255EC73A-C6D2-4198-B951-5C49F1DF4D62
P2860
Bioavailability of angiotensin I converting enzyme inhibitory peptides.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Bioavailability of angiotensin I converting enzyme inhibitory peptides.
@ast
Bioavailability of angiotensin I converting enzyme inhibitory peptides.
@en
type
label
Bioavailability of angiotensin I converting enzyme inhibitory peptides.
@ast
Bioavailability of angiotensin I converting enzyme inhibitory peptides.
@en
prefLabel
Bioavailability of angiotensin I converting enzyme inhibitory peptides.
@ast
Bioavailability of angiotensin I converting enzyme inhibitory peptides.
@en
P2860
P356
P1476
Bioavailability of angiotensin I converting enzyme inhibitory peptides.
@en
P2093
John Van Camp
Vanessa Vermeirssen
P2860
P304
P356
10.1079/BJN20041189
P577
2004-09-01T00:00:00Z